Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Total Liabilities (2010 - 2026)

Mimedx recorded quarterly Total Liabilities of $65.7 million in Q1 2026, down 23.65% quarter-over-quarter from $86.1 million in Q4 2025, and down 2.81% year-over-year from $67.6 million in Q1 2025.

Mimedx's Total Liabilities history runs 17 years deep, the most recent figure standing at $65.7 million for Q1 2026.

  • In Q1 2026, Total Liabilities fell 2.81% year-over-year to $65.7 million; the TTM figure through Mar 2026 stood at $65.7 million (down 2.81% YoY), while the FY2025 annual figure was $86.1 million, up 21.6% from the prior year.
  • Total Liabilities came in at $65.7 million for Q1 2026 at Mimedx, down from $86.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $99.8 million in Q3 2022 to a low of $62.1 million in Q2 2024.
  • A 5-year average of $82.0 million and a median of $86.1 million in 2025 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities sank 35.64% in 2024 and gained 27.29% in 2025, its largest moves.
  • Mimedx's Total Liabilities stood at $96.9 million in 2022, then slipped by 0.61% to $96.3 million in 2023, then decreased by 26.49% to $70.8 million in 2024, then increased by 21.6% to $86.1 million in 2025, then declined by 23.65% to $65.7 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $65.7 million, $86.1 million, and $80.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.74 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 177.22 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.12 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 10.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.45 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn 65.74 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 65.74 Mn
Dec 31, 2025 86.11 Mn
Sep 30, 2025 80.04 Mn
Jun 30, 2025 74.49 Mn
Mar 31, 2025 67.64 Mn
Dec 31, 2024 70.81 Mn
Sep 30, 2024 62.88 Mn
Jun 30, 2024 62.14 Mn
Mar 31, 2024 65.95 Mn
Dec 31, 2023 96.33 Mn
Sep 30, 2023 95.20 Mn
Jun 30, 2023 96.55 Mn
Mar 31, 2023 93.61 Mn
Dec 31, 2022 96.92 Mn
Sep 30, 2022 99.82 Mn
Jun 30, 2022 89.78 Mn
Mar 31, 2022 89.38 Mn
Dec 31, 2021 95.35 Mn
Sep 30, 2021 93.84 Mn
Jun 30, 2021 101.79 Mn
Mar 31, 2021 106.83 Mn
Dec 31, 2020 110.61 Mn
Sep 30, 2020 109.35 Mn
Jun 30, 2020 128.05 Mn
Mar 31, 2020 128.57 Mn
Dec 31, 2019 132.77 Mn
Sep 30, 2019 139.69 Mn
Jun 30, 2019 145.63 Mn
Mar 31, 2019 69.09 Mn
Dec 31, 2018 73.19 Mn
Sep 30, 2018 -84.71 Mn
Jun 30, 2018 -81.15 Mn
Mar 31, 2018 -75.26 Mn
Dec 31, 2017 47.46 Mn
Sep 30, 2017 36.24 Mn
Jun 30, 2017 52.60 Mn
Mar 31, 2017 59.46 Mn
Dec 31, 2016 69.21 Mn
Sep 30, 2016 58.39 Mn
Jun 30, 2016 55.45 Mn
Mar 31, 2016 62.98 Mn
Dec 31, 2015 27.93 Mn
Sep 30, 2015 25.41 Mn
Jun 30, 2015 20.60 Mn
Mar 31, 2015 19.70 Mn
Dec 31, 2014 19.93 Mn
Sep 30, 2014 16.06 Mn
Jun 30, 2014 11.54 Mn
Mar 31, 2014 11.11 Mn
Dec 31, 2013 11.13 Mn
Sep 30, 2013 9.76 Mn
Jun 30, 2013 7.39 Mn
Mar 31, 2013 6.26 Mn
Dec 31, 2012 15.18 Mn
Sep 30, 2012 14.35 Mn
Jun 30, 2012 11.80 Mn
Mar 31, 2012 14.36 Mn
Dec 31, 2011 15.20 Mn
Sep 30, 2011 11.70 Mn
Jun 30, 2011 11.36 Mn
Dec 31, 2010 1.25 Mn